Roam Robotics Launches Partnership with the San Francisco VA Health Care System

To study the impact of its robotic wearable on the Veteran population

Roam Robotics, the company leading the expansion of human mobility with wearable robotics, announced today that the San Francisco VA Health Care System (SFVAHCS), along with the Northern California Institute for Research and Education (NCIRE), has begun enrolling patients to study the impact of Ascend, a first-of-its-kind smart brace, on the Veteran population.

Ascend, from Roam Robotics, is a smart knee orthosis designed to provide relief from knee pain and intuitively support everyday mobility. A previous clinical study of knee osteoarthritis participants demonstrated an average of 46 percent pain reduction, and 67 percent exhibited functional improvement when using the device.  Ascend is the first wearable robotic device to show usefulness in everyday life for people suffering from knee joint pain who want to regain independence and live more active lifestyles.  Ascend is also registered with the FDA as a Class I medical device.

“I am excited to evaluate Roam Robotics’ Ascend powered knee-brace in Veterans with knee osteoarthritis who experience considerable knee pain when performing day-to-day activities,” said Dr. Alfred Kuo, Chief of Orthopedic Surgery at the San Francisco VA Health Care System “Veterans suffer from musculoskeletal conditions such as knee arthritis at higher rates than the general population.  We don’t have great treatment options for many of these patients, especially ones who have moderate disease. The Ascend brace has the potential to substantially improve pain, stability, and function.”

Ascend provides a non-opioid and non-surgical solution for pain relief and increased stability, while performing common movements like walking, kneeling, standing, sitting, and going up or down steps. “Roam’s technology has been proven previously to provide benefits to a wide variety of patients suffering from knee pain, weak quadriceps or instability,” said Sujit Dike, Vice President at Roam Robotics. “We are very excited about this partnership with the   San Francisco VA. It can further validate the potential impact of Roam’s technology in addressing an enormous and growing challenge for the Veteran population”.

“Roam is focused on a massively underserved market.  More than 20 percent of the global population is limited by their body’s mobility, and as medical advancements help people live longer that number is only going to increase,” said Tim Swift, Roam’s CEO and Founder.  “Our approach to wearable robotics works seamlessly with the human body to help people lead healthier, happier and more active lives, unhindered by physical limitations.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version